REFERENCES
- Krupitsky, E., Nunes, E., Ling, W., Illeperuma, A., Gastfriend, D., & Silverman, B. (2011). Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo controlled multicenter randomized trial. The Lancet, 337, 1506–1513.
- Krupitsky, E., Zvartau, E., Blokhina, E., Verbitskaya, E., Wahlgren, V., Tsoy-Podosenin, M., … Woody, G. E. (2012). Randomized trial of long acting sustained release naltrexone implant vs. oral naltrexone or placebo for preventing relapse to opioid dependence. Archives of General Psychiatry, 69(9), 973–981. NCT00678418, NIHMSID#449740.
- McLellan, A. T., Arndt, I. O., Metzger, D. S., Woody, G. E., & O'Brien, C. P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269(15), 1953–1959.
- McLellan, A. T., Alterman, A. I., Metzger, D. S., Grissom, G. R., Woody, G. E., Luborsky, L., & O'Brien, C. P. (1994). Similarity of outcome predictors across opiate, cocaine and alcohol treatments: Role of treatment services. Journal of Consulting and Clinical Psychology, 62, 1141–1158.
- McLellan, A. T., Alterman, A. I., Metzger, D. S., Grissom, G. R., Woody, G. E., Luborsky, L., & O'Brien, C. P. (1994). Similarity of outcome predictors across opiate, cocaine and alcohol treatments: Role of treatment services. Journal of Consulting and Clinical Psychology, 62, 1141–1158.
- Metzger, D. S., Woody, G. E., McLellan, A. T., Druley, P., DePhilippis, D., O'Brien, C. P., …Abrutyn, E. (1993). HIV conversion among in and out-of-treatment intravenous drug users in Philadelphia. Journal of Acquired Immune Deficiency Syndromes, 6(9), 1049–1056.
- Nunes, E. V., Quitkin, F. M., Donovan, S., Deliyannides, D., Ocepek-Welikson, K., Koenig, T., …Woody, G. (1998). Imipramine treatment of opiate dependent patients with depressive disorders: A placebo-controlled trial. Archives of General Psychiatry, 55, 153–160.
- Woody, G. E., McLellan, A. T., Luborsky, L. O'Brien, C. P., Blaine, J., Fox, S., …Beck, A. T. (1984). Psychiatric severity as a predictor of benefits from psychotherapy: The penn-va study. The American Journal of Psychiatry, 141, 1172–1177.
- Woody, G. E., Kane, V., Lewis, K., & Thompson, R. (2007). Premature deaths following discharge from methadone maintenance: A replication. Journal of Addiction Medicine, 1(4), 180–185.
- Woody, G. E., Poole, S., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbot, P., …Fudala, P. (2008). Extended vs. short-term buprenorphine-naloxone for treatment of opioid addicted youth: A randomized trial. JAMA, 300(17), 2002–2011. PMC2610690.
- Woody, G. E., & Metzger, D. S. (2011). Injectable extended release naltrexone for opioid dependence. Lancet, 378, 664–665. PMID: 21856476
- Wu, L. T., Gersing, K., Burchett, B., Woody, G. E., & Blazer, D. G. (2011). Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: Findings from a large electronic health records database. Journal of Psychiatric Research, 45(11), 1453–1462. PMC3196279
- Wu, L. T., Woody, G. E., Yang, C., Manneli, P., & Blazer, D. G. (2011). Differences in onset, duration, and disorder episode between prescription opioid use disorders and heroin use disorders: Results from the national epidemiologic survey on alcohol and related conditions. Substance Abuse and Rehabilitation, 2, 1–12. PMC3114372.